These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6164285)

  • 1. Electrophysiologic effects of N-acetylprocainamide in human beings.
    Jaillon P; Rubenson D; Peters F; Mason JW; Winkle RA
    Am J Cardiol; 1981 May; 47(5):1134-40. PubMed ID: 6164285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic properties and antiarrhythmic mechanisms of intravenous N-acetylprocainamide in patients with ventricular dysrhythmias.
    Sung RJ; Juma Z; Saksena S
    Am Heart J; 1983 May; 105(5):811-9. PubMed ID: 6189384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electropharmacodynamics of N-acetylprocainamide in the immature mammalian heart--evidence for a prominent class III effect in the newborn.
    Dise T; Stolfi A; Yamasaki S; Pickoff AS
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):96-101. PubMed ID: 1708063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine electrophysiology of encainide, a new antiarrhythmic drug.
    Sami M; Mason JW; Oh G; Harrison DC
    Am J Cardiol; 1979 Jun; 43(6):1149-54. PubMed ID: 443174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
    Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
    Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical electrophysiologic effects of encainide, a newly developed antiarrhythmic agent.
    Sami M; Mason JW; Peters F; Harrison DC
    Am J Cardiol; 1979 Sep; 44(3):526-32. PubMed ID: 474433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of procainamide and its N-acetylated metabolite in conscious dogs with atrioventricular block: plasma concentration-response relationships.
    Boucher M; Dubray C; Paire M; Duchêne-Marullaz P
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):562-7. PubMed ID: 2447406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic comparative study of procainamide and N-acetylprocainamide in anesthetized dogs: concentration-response relationships.
    Jaillon P; Winkle RA
    Circulation; 1979 Dec; 60(6):1385-94. PubMed ID: 91451
    [No Abstract]   [Full Text] [Related]  

  • 9. The discordant influences of infarct healing on the electrophysiologic effects of procainamide and N-acetylprocainamide.
    Nelson SD; Coyne KS; Meimer J
    J Pharmacol Exp Ther; 1995 Apr; 273(1):315-9. PubMed ID: 7536244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylprocainamide induced changes in refractoriness and monophasic action potentials of the dog heart in situ.
    Amlie JP; Landmark K
    Cardiovasc Res; 1981 Mar; 15(3):159-63. PubMed ID: 6167356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
    Funck-Brentano C; Light RT; Lineberry MD; Wright GM; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine.
    Okumura K; Waldo AL
    J Am Coll Cardiol; 1987 Jun; 9(6):1332-8. PubMed ID: 2438320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiology of esmolol.
    Greenspan AM; Spielman SR; Horowitz LN; Senior S; Steck J; Laddu A
    Am J Cardiol; 1985 Oct; 56(11):19F-26F. PubMed ID: 2864844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic effects of intravenous nicardipine on sinus node function and conduction in humans.
    David D; Guize L; Leheuzey JY; Lavergne T; Loria Y; Ourbak P
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):130-7. PubMed ID: 1688970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The electrophysiologic effects of procainamide in the immature heart.
    Shih JY; Gillette PC; Kugler JD; Garson A; Fukushige J; Zinner A; Driscoll DJ
    Pediatr Pharmacol (New York); 1982; 2(1):65-73. PubMed ID: 7110758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intravenous N-acetylprocainamide on hemodynamics and left ventricular function in man.
    Josephson MA; Schwab M; Coyle K; Singh BN
    Am Heart J; 1987 Apr; 113(4):952-7. PubMed ID: 2436466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic effects of dopamine on the cardiac conduction system (author's transl)].
    Bischoff KO; Hager W; Bödeker K
    Z Kardiol; 1981 Sep; 70(9):643-51. PubMed ID: 7303803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide.
    Atkinson AJ; Ruo TI; Piergies AA
    Angiology; 1988 Jul; 39(7 Pt 2):655-67. PubMed ID: 2457345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels and electrophysiological effects of N-acetlyprocainamide as compared with procainamide in the dog heart in situ.
    Amlie JP; Nesje OA; Frislid K; Lunde PK; Landmark K
    Acta Pharmacol Toxicol (Copenh); 1978 Apr; 42(4):280-6. PubMed ID: 580675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic effects of procainamide in subtherapeutic to therapeutic doses on human atrioventricular conduction system.
    Ogunkelu JB; Damato AN; Akhtar M; Reddy CP; Caracta AR; Lau SH
    Am J Cardiol; 1976 Apr; 37(5):724-31. PubMed ID: 773160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.